Oil & Gas Equipment & Services
Compare Stocks
2 / 10Stock Comparison
NOV vs BKR
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Equipment & Services
NOV vs BKR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services |
| Market Cap | $6.96B | $63.00B |
| Revenue (TTM) | $8.69B | $27.89B |
| Net Income (TTM) | $91M | $3.12B |
| Gross Margin | 19.5% | 23.6% |
| Operating Margin | 5.3% | 25.3% |
| Forward P/E | 21.7x | 26.5x |
| Total Debt | $2.34B | $7.14B |
| Cash & Equiv. | $1.55B | $3.71B |
NOV vs BKR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NOV Inc. (NOV) | 100 | 154.8 | +54.8% |
| Baker Hughes Company (BKR) | 100 | 384.8 | +284.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOV vs BKR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOV is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 5 yrs, beta 1.01, yield 2.6%
- Lower volatility, beta 1.01, Low D/E 37.0%, current ratio 2.42x
- Beta 1.01, yield 2.6%, current ratio 2.42x
BKR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -0.3%, EPS growth -12.8%, 3Y rev CAGR 9.4%
- 186.8% 10Y total return vs NOV's -31.8%
- -0.3% revenue growth vs NOV's -1.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.3% revenue growth vs NOV's -1.4% | |
| Value | Lower P/E (21.7x vs 26.5x) | |
| Quality / Margins | 11.2% margin vs NOV's 1.0% | |
| Stability / Safety | Beta 0.83 vs NOV's 1.01 | |
| Dividends | 2.6% yield, 5-year raise streak, vs BKR's 1.4% | |
| Momentum (1Y) | +77.5% vs NOV's +67.6% | |
| Efficiency (ROA) | 7.3% ROA vs NOV's 0.8%, ROIC 12.7% vs 5.8% |
NOV vs BKR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NOV vs BKR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BKR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BKR is the larger business by revenue, generating $27.9B annually — 3.2x NOV's $8.7B. BKR is the more profitable business, keeping 11.2% of every revenue dollar as net income compared to NOV's 1.0%. On growth, BKR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8.7B | $27.9B |
| EBITDAEarnings before interest/tax | $725M | $4.5B |
| Net IncomeAfter-tax profit | $91M | $3.1B |
| Free Cash FlowCash after capex | $734M | $2.6B |
| Gross MarginGross profit ÷ Revenue | +19.5% | +23.6% |
| Operating MarginEBIT ÷ Revenue | +5.3% | +25.3% |
| Net MarginNet income ÷ Revenue | +1.0% | +11.2% |
| FCF MarginFCF ÷ Revenue | +8.4% | +9.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -73.7% | +132.5% |
Valuation Metrics
NOV leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 24.4x trailing earnings, BKR trades at a 51% valuation discount to NOV's 49.5x P/E. On an enterprise value basis, NOV's 8.4x EV/EBITDA is more attractive than BKR's 14.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.0B | $63.0B |
| Enterprise ValueMkt cap + debt − cash | $7.7B | $66.4B |
| Trailing P/EPrice ÷ TTM EPS | 49.49x | 24.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.73x | 26.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.43x | 14.00x |
| Price / SalesMarket cap ÷ Revenue | 0.80x | 2.27x |
| Price / BookPrice ÷ Book value/share | 1.14x | 3.32x |
| Price / FCFMarket cap ÷ FCF | 8.06x | 24.83x |
Profitability & Efficiency
BKR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BKR delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $1 for NOV. NOV carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to BKR's 0.38x. On the Piotroski fundamental quality scale (0–9), BKR scores 6/9 vs NOV's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +1.4% | +16.1% |
| ROA (TTM)Return on assets | +0.8% | +7.3% |
| ROICReturn on invested capital | +5.8% | +12.7% |
| ROCEReturn on capital employed | +6.3% | +13.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.37x | 0.38x |
| Net DebtTotal debt minus cash | $788M | $3.4B |
| Cash & Equiv.Liquid assets | $1.6B | $3.7B |
| Total DebtShort + long-term debt | $2.3B | $7.1B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | 9.68x |
Total Returns (Dividends Reinvested)
BKR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKR five years ago would be worth $27,526 today (with dividends reinvested), compared to $11,957 for NOV. Over the past 12 months, BKR leads with a +77.5% total return vs NOV's +67.6%. The 3-year compound annual growth rate (CAGR) favors BKR at 33.1% vs NOV's 8.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +18.2% | +35.7% |
| 1-Year ReturnPast 12 months | +67.6% | +77.5% |
| 3-Year ReturnCumulative with dividends | +29.3% | +136.0% |
| 5-Year ReturnCumulative with dividends | +19.6% | +175.3% |
| 10-Year ReturnCumulative with dividends | -31.8% | +186.8% |
| CAGR (3Y)Annualised 3-year return | +8.9% | +33.1% |
Risk & Volatility
Evenly matched — NOV and BKR each lead in 1 of 2 comparable metrics.
Risk & Volatility
BKR is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than NOV's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.01x | 0.83x |
| 52-Week HighHighest price in past year | $20.93 | $70.41 |
| 52-Week LowLowest price in past year | $11.65 | $35.83 |
| % of 52W HighCurrent price vs 52-week peak | +92.2% | +90.2% |
| RSI (14)Momentum oscillator 0–100 | 55.4 | 57.1 |
| Avg Volume (50D)Average daily shares traded | 4.8M | 9.1M |
Analyst Outlook
NOV leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates NOV as "Hold" and BKR as "Buy". Consensus price targets imply 13.3% upside for BKR (target: $72) vs 0.4% for NOV (target: $19). For income investors, NOV offers the higher dividend yield at 2.63% vs BKR's 1.44%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $19.38 | $72.00 |
| # AnalystsCovering analysts | 58 | 45 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +1.4% |
| Dividend StreakConsecutive years of raises | 5 | 4 |
| Dividend / ShareAnnual DPS | $0.51 | $0.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.5% | +0.6% |
BKR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NOV leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
NOV vs BKR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NOV or BKR a better buy right now?
For growth investors, Baker Hughes Company (BKR) is the stronger pick with -0.
3% revenue growth year-over-year, versus -1. 4% for NOV Inc. (NOV). Baker Hughes Company (BKR) offers the better valuation at 24. 4x trailing P/E (26. 5x forward), making it the more compelling value choice. Analysts rate Baker Hughes Company (BKR) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOV or BKR?
On trailing P/E, Baker Hughes Company (BKR) is the cheapest at 24.
4x versus NOV Inc. at 49. 5x. On forward P/E, NOV Inc. is actually cheaper at 21. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NOV or BKR?
Over the past 5 years, Baker Hughes Company (BKR) delivered a total return of +175.
3%, compared to +19. 6% for NOV Inc. (NOV). Over 10 years, the gap is even starker: BKR returned +186. 8% versus NOV's -31. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOV or BKR?
By beta (market sensitivity over 5 years), Baker Hughes Company (BKR) is the lower-risk stock at 0.
83β versus NOV Inc. 's 1. 01β — meaning NOV is approximately 21% more volatile than BKR relative to the S&P 500. On balance sheet safety, NOV Inc. (NOV) carries a lower debt/equity ratio of 37% versus 38% for Baker Hughes Company — giving it more financial flexibility in a downturn.
05Which is growing faster — NOV or BKR?
By revenue growth (latest reported year), Baker Hughes Company (BKR) is pulling ahead at -0.
3% versus -1. 4% for NOV Inc. (NOV). On earnings-per-share growth, the picture is similar: Baker Hughes Company grew EPS -12. 8% year-over-year, compared to -75. 6% for NOV Inc.. Over a 3-year CAGR, BKR leads at 9. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOV or BKR?
Baker Hughes Company (BKR) is the more profitable company, earning 9.
3% net margin versus 1. 7% for NOV Inc. — meaning it keeps 9. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BKR leads at 12. 8% versus 6. 5% for NOV. At the gross margin level — before operating expenses — BKR leads at 23. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOV or BKR more undervalued right now?
On forward earnings alone, NOV Inc.
(NOV) trades at 21. 7x forward P/E versus 26. 5x for Baker Hughes Company — 4. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BKR: 13. 3% to $72. 00.
08Which pays a better dividend — NOV or BKR?
All stocks in this comparison pay dividends.
NOV Inc. (NOV) offers the highest yield at 2. 6%, versus 1. 4% for Baker Hughes Company (BKR).
09Is NOV or BKR better for a retirement portfolio?
For long-horizon retirement investors, Baker Hughes Company (BKR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
83), 1. 4% yield, +186. 8% 10Y return). Both have compounded well over 10 years (BKR: +186. 8%, NOV: -31. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOV and BKR?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.